A robust automated segmentation method for white matter hyperintensity of vascular-origin.
Journal:
NeuroImage
Published Date:
May 17, 2025
Abstract
White matter hyperintensity (WMH) is a primary manifestation of small vessel disease (SVD), leading to vascular cognitive impairment and other disorders. Accurate WMH quantification is vital for diagnosis and prognosis, but current automatic segmentation methods often fall short, especially across different datasets. The aims of this study are to develop and validate a robust deep learning segmentation method for WMH of vascular-origin. In this study, we developed a transformer-based method for the automatic segmentation of vascular-origin WMH using both 3D T1 and 3D T2-FLAIR images. Our initial dataset comprised 126 participants with varying WMH burdens due to SVD, each with manually segmented WMH masks used for training and testing. External validation was performed on two independent datasets: the WMH Segmentation Challenge 2017 dataset (170 subjects) and an in-house vascular risk factor dataset (70 subjects), which included scans acquired on eight different MRI systems at field strengths of 1.5T, 3T, and 5T This approach enabled a comprehensive assessment of the method's generalizability across diverse imaging conditions. We further compared our method against LGA, LPA, BIANCA, UBO-detector and TrUE-Net in optimized settings. Our method consistently outperformed others, achieving a median Dice coefficient of 0.78 ± 0.09 in our primary dataset, 0.72 ± 0.15 in the external dataset 1, and 0.72 ± 0.14 in the external dataset 2. The relative volume errors were 0.15 ± 0.14, 0.50 ± 0.86, and 0.47 ± 1.02, respectively. The true positive rates were 0.81 ± 0.13, 0.92 ± 0.09, and 0.92 ± 0.12, while the false positive rates were 0.20 ± 0.09, 0.40 ± 0.18, and 0.40 ± 0.19. None of the external validation datasets were used for model training; instead, they comprise previously unseen MRI scans acquired from different scanners and protocols. This setup closely reflects real-world clinical scenarios and further demonstrates the robustness and generalizability of our model across diverse MRI systems and acquisition settings. As such, the proposed method provides a reliable solution for WMH segmentation in large-scale cohort studies.